CASP3 and neoplasm: The results have shown that GLN supplementation caused a significant decrease by 57% in tumor GSH levels and similar ratio GSH/oxidized GSH (GSSG) accompanied by upregulation of Bax and caspase-3 (apoptosis induced factors) and downregulation of Bcl-2 (apoptosis inhibiting factor).